TSX:KHRN
Khiron Life Sciences Corp.
- Stock
Last Close
0.04
05/05 14:54
Volume Today
24K
Avg: 269.50K
PE Ratio
−0.20
PFCF: −0.41
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|
average inventory | 4.65M - | 8.90M 91.33% | ||
average payables | 6.85M - | 5.29M 22.82% | ||
average receivables | 4.41M - | 3.73M 15.41% | ||
book value per share | 0.69 - | 0.53 23.48% | 0.20 61.46% | |
capex per share | -0.06 - | -0.02 62.54% | -0.01 52.65% | |
capex to depreciation | 6.49 - | 2.31 64.48% | 1.56 32.19% | |
capex to operating cash flow | 0.20 - | 0.11 45.83% | 0.08 23.86% | |
capex to revenue | -0.64 - | -0.34 47.18% | -0.14 59.43% | |
cash per share | 0.36 - | 0.18 50.28% | 0.05 69.86% | |
days of inventory on hand | 46.68 - | 421.82 803.67% | 347.85 17.54% | |
days payables outstanding | 360.98 - | 316.93 12.20% | 158.51 49.99% | |
days sales outstanding | 161.48 - | 208.67 29.22% | 82.16 60.63% | |
debt to assets | 0.04 - | 0.04 12.08% | 0.05 38.16% | |
debt to equity | 0.05 - | 0.04 12.99% | 0.07 51.41% | |
dividend yield | ||||
earnings yield | -0.34 - | -0.53 58.33% | -0.96 79.94% | |
enterprise value | 102.29M - | 26.25M 74.34% | 27.85M 6.10% | |
enterprise value over ebitda | -2.93 - | -0.94 67.98% | -1.31 39.86% | |
ev to operating cash flow | -3.40 - | -1.07 68.54% | -1.33 24.75% | |
ev to sales | 10.67 - | 3.27 69.33% | 2.18 33.52% | |
free cash flow per share | -0.35 - | -0.23 36.20% | -0.14 39.28% | |
free cash flow yield | -0.33 - | -0.60 80.35% | -0.65 8.43% | |
graham net net | 0.28 - | 0.16 42.97% | 0.04 73.99% | |
graham number | 2.35 - | 1.54 34.53% | 0.96 37.68% | |
income quality | 0.83 - | 1.02 23.44% | 0.63 38.29% | |
intangibles to total assets | 0.30 - | 0.32 7.81% | 0.21 33.17% | |
interest coverage | -62.25 - | -50.18 19.39% | ||
interest debt per share | 0.03 - | 0.03 22.25% | 0.02 40.04% | |
inventory turnover | 7.82 - | 0.87 88.93% | 1.05 21.26% | |
invested capital | 0.05 - | 0.04 12.99% | 0.07 51.41% | |
market cap | 108.08M - | 45.11M 58.26% | 34.55M 23.41% | |
net current asset value | 32.94M - | 26.46M 19.65% | 14.83M 43.96% | |
net debt to ebitda | 0.17 - | 0.67 306.21% | 0.32 53.20% | |
net income per share | -0.36 - | -0.20 43.99% | -0.20 0.77% | |
operating cash flow per share | -0.29 - | -0.20 30.86% | -0.13 37.81% | |
payables turnover | 1.01 - | 1.15 13.90% | 2.30 99.94% | |
receivables turnover | 2.26 - | 1.75 22.61% | 4.44 153.99% | |
research and ddevelopement to revenue | 0.39 - | 0.19 51.14% | 0.10 50.06% | |
return on tangible assets | -0.63 - | -0.48 23.52% | -1.00 106.46% | |
revenue per share | 0.09 - | 0.07 29.08% | 0.08 16.70% | |
roe | -0.52 - | -0.38 26.80% | -0.99 161.45% | |
roic | -0.49 - | -0.44 9.09% | -0.62 39.83% | |
sales general and administrative to revenue | 3.25 - | 3.23 0.48% | 1.67 48.39% | |
shareholders equity per share | 0.69 - | 0.53 23.48% | 0.20 61.46% | |
stock based compensation to revenue | 0.98 - | 0.71 27.09% | 0.18 74.55% | |
tangible asset value | 45.79M - | 39.87M 12.92% | 24.31M 39.02% | |
tangible book value per share | 0.45 - | 0.33 26.19% | 0.15 55.41% | |
working capital | 36.37M - | 29.07M 20.06% | 16.06M 44.77% |
All numbers in (except ratios and percentages)